Hironari Shiwaku

Hironari Shiwaku

Auto-generated profile, based on publicly available information

Hironari Shiwaku

Department of Gastroenterological Surgery Fukuoka University Faculty of Medicine Fukuoka Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2019 in Esophagus
Verified
Journal Article
Open access
PDF file
HIHaruhiro Inoue
Haruhiro Inoue
HSHironari Shiwaku
Hironari Shiwaku
YKYasutoshi Kobayashi
Yasutoshi Kobayashi
PCPhilip W. Y. Chiu
Philip W. Y. Chiu
RHRobert H. Hawes
Robert H. Hawes
HTHisao Tajiri
Hisao Tajiri
It has been 10 years since peroral endoscopic myotomy (POEM) was reported for the first time, and POEM has currently become the standard treatment for achalasia and related disorders globally because it is less invasive and has a higher curative effect than conventional therapeutic methods. However, there are limited studies comparing the long-term outcomes of POEM with those of conventional therapeutic methods, particularly in the occurrence of gastroesophageal reflux disease (GERD) after therapy. With this background, we held a consensus meeting to discuss the pathophysiology and management of GERD after POEM based on published papers and experiences of each expert and to discuss the prevention of GERD and dealing with anti-acid drug refractory GERD. This meeting was held on April 27, 2018 in Tokyo to establish statements and finalize the recommendations using the modified Delphi method. This manuscript presents eight statements regarding GERD after POEM.

1 May 2020 in Gastrointestinal Endoscopy
Verified
Journal Article
Open access
HSHironari Shiwaku
Hironari Shiwaku
HIHaruhiro Inoue
Haruhiro Inoue
HSHiroki Sato
Hiroki Sato
MOManabu Onimaru
Manabu Onimaru
HMHitomi Minami
Hitomi Minami
HYHiroshi Yokomichi
Hiroshi Yokomichi
Peroral endoscopic myotomy (POEM) is an available treatment modalities for achalasia. The reported efficacy of POEM in the only prospective multicenter study was 82%; however, a retrospective multicenter study in Japan reported a higher efficacy rate of 95%. The aim of this study was to prospectively verify treatment outcomes after POEM at multiple facilities in Japan. This was a prospective single-arm trial of POEM for achalasia at 8 facilities in Japan between April 2016 and March 2018 to evaluate its safety and efficacy. Patients were re-evaluated at 3 months and up to 1 year after POEM. Among the 233 patients with achalasia who underwent POEM, procedure-related adverse events occurred in 24 patients (10.3%), none of whom required surgical intervention. In the 207 patients satisfying the inclusion criteria, the efficacy rate of POEM, defined by an Eckardt score ≤3 at 1 year, was 97.4% (95% CI, 95.3%-99.7%). The Eckardt score decreased significantly from 6.6 ± 2.0 preoperatively to 1.1 ± 1.1, 1 year after POEM. Postoperative reflux esophagitis, severe reflux esophagitis, and symptomatic GERD were reported in 54.2%, 5.6%, and 14.7%, respectively, and proton pump inhibitors were administered in 21.1%. Our prospective multicenter study in Japan showed greater efficacy of POEM for achalasia compared with the results of a previous prospective multicenter study. POEM is safe and highly effective for at least 1 year. (Clinical trial registration number: UMIN 000021550.).

1 March 2016 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
HSHironari Shiwaku
Hironari Shiwaku
HIHaruhiro Inoue
Haruhiro Inoue
KYKanefumi Yamashita
Kanefumi Yamashita
TOToshihiro Ohmiya
Toshihiro Ohmiya
RBRichiko Beppu
Richiko Beppu
YYYuichi Yamashita
Yuichi Yamashita

28 September 2015 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
HSHironari Shiwaku
Hironari Shiwaku
HIHaruhiro Inoue
Haruhiro Inoue
TSTakamitsu Sasaki
Takamitsu Sasaki
KYKanefumi Yamashita
Kanefumi Yamashita
TOToshihiro Ohmiya
Toshihiro Ohmiya
YYYuichi Yamashita
Yuichi Yamashita
Background: Peroral endoscopic myotomy (POEM) is an emerging, minimally invasive procedure capable of overcoming limitations of achalasia treatments, but gastroesophageal reflux disease (GERD) after POEM is of concern and its risk factors have not been evaluated. This prospective study examined GERD and the association of POEM with reflux esophagitis.Methods: Achalasia patients were recruited from a single center. The pre- and postoperative assessments included Eckardt scores, manometry, endoscopy, and pH monitoring.Results: Between September 2011 and November 2014, 105 patients underwent POEM; 70 patients were followed up 3 months after POEM. Postoperatively, significant reductions were observed in lower esophageal sphincter (LES) pressure [from 40.0 ± 22.8 to 20.7 ± 14.0 mmHg (P < 0.05)], LES residual pressure [from 22.1 ± 13.3 to 11.4 ± 6.6 mmHg (P < 0.05)], and Eckardt scores [from 5.7 ± 2.5 to 0.7 ± 0.8 (P < 0.05)]. Symptomatic GERD and moderate reflux esophagitis developed in 5 and 11 patients (grade B,n = 8; grade C,n = 3), respectively, and were well controlled with proton pump inhibitors. Univariate logistic regression analysis revealed integrated relaxation pressure was a predictor of ≥grade B reflux esophagitis. No POEM factors were found to be associated with reflux esophagitis.Conclusion: POEM is effective and safe in treating achalasia, with no occurrence of clinically significant refractory GERD. Myotomy during POEM, especially of the gastric side, was not associated with ≥grade B (requiring medical intervention) reflux esophagitis. Extended gastric myotomy (2–3 cm) during POEM is recommended to improve outcomes.

16 February 2022 in Endoscopy
Verified
Journal Article
Closed access
PDF file
HSHironari Shiwaku
Hironari Shiwaku
HSHiroki Sato
Hiroki Sato
YSYuto Shimamura
Yuto Shimamura
HAHirofumi Abe
Hirofumi Abe
JSJunya Shiota
Junya Shiota
HIHaruhiro Inoue
Haruhiro Inoue
Background Gastroesophageal reflux disease (GERD) and reflux esophagitis remain problems after peroral endoscopic myotomy (POEM). This study aimed to elucidate the risk factors and long-term course of reflux esophagitis and symptomatic GERD after POEM. Methods This multicenter cohort study involved 14 high volume centers. Overall, 2905 patients with achalasia-related esophageal motility disorders treated with POEM were analyzed for reflux esophagitis, severe reflux esophagitis (Los Angeles classification C or D), and symptomatic GERD. Results Reflux esophagitis was diagnosed in 1886 patients (64.9 %). Age ≥ 65 years (risk ratio [RR] 0.85), male sex (RR 1.11), posterior myotomy (RR 1.12), esophageal myotomy > 10 cm (RR 1.12), and gastric myotomy > 2 cm (RR 1.17) were independently associated with reflux esophagitis. Severe reflux esophagitis was diagnosed in 219 patients (7.5 %). Age ≥ 65 years (RR 1.72), previous treatments (RR 2.21), Eckardt score ≥ 7 (RR 0.68), sigmoid-type achalasia (RR 1.40), and esophageal myotomy > 10 cm (RR 1.59) were factors associated with severe reflux esophagitis. Proton pump inhibitors (PPIs) were more effective for reflux esophagitis at 5-year follow-up (P = 0.03) than after 1 year (P = 0.08). Symptomatic GERD was present in 458 patients (15.9 %). Symptom duration ≥ 10 years (RR 1.28), achalasia diagnosis (RR 0.68), integrated relaxation pressure ≥ 26 (RR 0.60), and posterior myotomy (RR 0.80) were associated with symptomatic GERD. The incidence of symptomatic GERD was lower at 5-year follow-up compared with that after 1 year (P = 0.04), particularly in PPI users (P < 0.001). Conclusions The incidence of severe reflux esophagitis was low after POEM, but excessive myotomy for older patients with previous treatments should be avoided. Early phase symptomatic GERD is non-acid reflux dependent and the natural course is favorable, basically supporting conservative treatment.

29 October 2021 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
HSHironari Shiwaku
Hironari Shiwaku
HIHaruhiro Inoue
Haruhiro Inoue
ASAkio Shiwaku
Akio Shiwaku
HOHiroki Okada
Hiroki Okada
SHSuguru Hasegawa
Suguru Hasegawa